A researcher at the University of Missouri has made a promising breakthrough in the quest to help people with amyotrophic ...

The 4-dose KwikPen device supports weight reduction in patients with obesity or overweight with weight-related conditions.

Since 2021, the story of GLP-1s has illustrated that scientific progress is rarely a straight line from hypothesis to patient ...

The Trump administration has pledged to conduct its own studies, but research continues to contradict its claims.

Biocon secures USFDA approval for generic Liraglutide, entering the lucrative US obesity treatment market with gSaxenda.

Indian drugmaker Dr Reddy's Laboratories is likely to launch its generic semaglutide injection in the country in March under the brand name Obeda, according to two people familiar with the matter as ...

Though increasingly prescribed in the U.S., a 2025 study linked gabapentin prescriptions for chronic low back pain with ...

You can take ashwaganda at any time of the day. Depending on why you're taking it, it can help with stress, anxiety, exercise recovery, and better sleep.

Dame Prue Leith has admitted she had to quit using weight-loss jabs after just a month. The former Great British Bake Off judge said she couldn’t contemplate "a life without hunger" during her brief ...

The FDA has approved a label expansion for once-weekly tirzepatide for adults with overweight and obesity, allowing the medication to be used with a pen that is equipped with four doses of the drug, ...

Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

They’re the seemingly miraculous solution to weight loss, helping people shed stubborn pounds that other diet and food ...